Expression of secretory leukocyte proteinase inhibitor in the submandibular glands of AIDS patients

Oral Diseases

Volumn 14, Issue 1, 2008, Pages 82-88

  Rocha, L A ^b   Vargas, P A ^b   Silva, L F F ^a   Leon, J E ^b   Santos, A B ^a   Hiemstra, P S ^c   Mauad, T ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

AIDS; Autopsy; Cytomegalovirus; Immunohistochemistry; Secretory leukocyte proteinase inhibitor; Submandibular gland

Indexed keywords

SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; MYCOBACTERIOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIALOADENITIS; STATISTICAL SIGNIFICANCE; SUBMANDIBULAR GLAND;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CAUSE OF DEATH; CHRONIC DISEASE; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HIV SERONEGATIVITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; SIALADENITIS; SUBMANDIBULAR GLAND; SUBMANDIBULAR GLAND DISEASES;

EID: 37349081243     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2006.01358.x     Document Type: Article

References (30)

1. Aarbiou J, van Schadewijk A, Stolk J et al (2004). Human neutrophil defensins and secretory leukocyte proteinase inhibitor in squamous metaplastic epithelium of bronchial airways. Inflamm Res 53: 230 238.
2. Angelov N, Moutsopoulos N, Jeong MJ, Nares S, Ashcroft G, Wahl SM (2004). Aberrant mucosal wound repair in the absence of secretory leukocyte protease inhibitor. Thromb Haemost 92: 288 297.
3. Beppu Y, Imamura Y, Tashiro M, Towatari T, Ariga H, Kido H (1997). Human mucus protease inhibitor in airway fluids is a potential defensive compound against infection with influenza A and Sendai viruses. J Biochem 121: 309 316.
4. Bruner JM, Cleary KR, Smith FB, Batsakis JG (1989). Immunocytochemical identification of HIV (p24) antigen in parotid lymphoid lesions. J Laryngol Otol 103: 1063 1066.
5. Chattopadhyay A, Gray LR, Patton LL et al (2004). Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1- infected persons. Infect Immun 72: 1956 1963.
6. Ding A, Yu H, Yang J, Shi S, Ehrt S (2005). Induction of macrophage-derived SLPI by Mycobacterium tuberculosis depends on TLR2 but not MyD88. Immunology 116: 381 389.
7. Doumas S, Kolokotronis A, Stefanopoulos P (2005). Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor. Infect Immun 73: 1271 1274.
8. Elliott JN, Oertel YC (1990). Lymphoepithelial cysts of the salivary glands. Histologic and cytologic features. Am J Clin Pathol 93: 39 43.
9. de Faria PR, Vargas PA, Saldiva PH, Bohm GM, Mauad T, de Almeida OP (2005). Tongue disease in advanced AIDS. Oral Dis 11: 72 80.
10. Gordon SB, Janoff EN, Sloper D et al (2005). HIV-1 infection is associated with altered innate pulmonary immunity. J Infect Dis 192: 1412 1416.
11. Griffiths PD (2006). CMV as a cofactor enhancing progression of AIDS. J Clin Virol 35: 489 492.
12. Hiemstra PS (2002). Novel roles of protease inhibitors in infection and inflammation. Biochem Soc Trans 30: 116 120.
13. Hiemstra PS, Fernie-King BA, McMichael J, Lachmann PJ, Sallenave JM (2004). Antimicrobial peptides: mediators of innate immunity as templates for the development of novel anti-infective and immune therapeutics. Curr Pharm Des 10: 2891 2905.
14. Jana NK, Gray LR, Shugars DC (2005). Human immunodeficiency virus Type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity. J Virol 79: 6432 6440.
15. Lin AL, Johnson DA, Stephan KT, Yeh C (2004). Salivary secretory leukocyte protease inhibitor increases in HIV infection. J Oral Pathol Med 33: 410 416.
16. Ma G, Greenwell-Wild T, Lei K et al (2004). Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection. J Exp Med 200: 1337 1346.
17. McNeely TB, Dealy M, Dripps DJ, Orenstein JM, Eisenberg SP, Wahl SM (1995). Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J Clin Invest 96: 456 464.
18. McNeely TB, Tucker C, Shugars DC, Rosendahl M, Eisenberg SP, Wahl SM (1997). Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to reverse transcription. Blood 90: 1141 1149.
19. Ohlsson M, Fryksmark U, Polling A, Tegner H, Ohlsson K (1984). Localization of antileukoprotease in the parotid and the submandibular salivary glands. Acta Otolaryngol 98: 147 151.
20. Sallenave JM (2002). Antimicrobial activity of antiproteinases. Biochem Soc Trans 30: 111 115.
21. Shugars DC, Wahl SM (1998). The role of the oral environment in HIV-1 transmission. J Am Dent Assoc 129: 851 858.
22. Shugars DC, Sauls DL, Weinberg JB (1997). Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type I. Oral Dis 3: S70 S72.
23. Shugars DC, Alexander AL, Fu K, Freel SA (1999). Endogenous salivary inhibitors of human immunodeficiency virus. Arch Oral Biol 44: 445 453.
24. Sorensen OE, Cowland JB, Theilgaard-Monch K, Liu L, Ganz T, Borregaard N (2003). Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol 170: 5583 5589.
25. Steininger C, Puchhammer-Stockl E, Popow-Kraupp T (2006). Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART). J Clin Virol 37: 1 9.
26. Thompson RC, Ohlsson K (1986). Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci U S A 83: 6692 6696.
27. Vargas PA, Mauad T, Böhm GM, Saldiva PHN, Almeida OP (2003). Parotid gland involvement in advanced AIDS. Oral Dis 9: 55 61.
28. Wahl SM, Worley P, Jin W et al (1997a). Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues. Am J Pathol 150: 1275 1284.
29. Wahl SM, McNeely TB, Janoff EN et al (1997b). Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I. Oral Dis 3: S64 S69.
30. Wang X, Huong SM, Chiu ML, Raab-Traub N, Huang ES (2003). Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus. Nature 424: 456 461.